Maria Palasis of Arsenal Medical, Inc. in the U.S. proposes to develop a hemostatic foam device that can be delivered into the uterus to control bleeding following childbirth. Success in this effort will significantly reduce maternal death in the developing world by providing an effective yet simple and inexpensive medical device that is compatible with existing infrastructure.
Information taken from Gates Foundation Grand Challenges Exploration Grants, awarded grants summaries.
Funding Source
Bill & Melinda Gates Foundation